Immunology Investor Event slide image

Immunology Investor Event

Our strategic roadmap to win in Immunology Building an Immunology Megabrand DUPIXENT>> (dupilumab) Strong internal immunology science Combined with value-creating external Business Development World-class leadership team Deep bench of talent with diverse backgrounds Advancing innovative pipeline First-in-Class/ Best-in-Class potential in new therapeutic fields 8 Immunology Investor Event sanofi Immunology Sales >4x €5.5bn €2.3bn 2019 2021 2030e sanofi
View entire presentation